Novel Methods for Implementing Measurement-Based Care for Youth in Low-resource Environments
Launched by KAISER PERMANENTE · Nov 30, 2022
Trial Information
Current as of January 17, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving mental health care for young people in Washington state by using regular questionnaires to measure how well treatments are working. The study will take place in four community mental health clinics, where the research team will work closely with clinic staff to understand any challenges they face in using these questionnaires. The goal is to find ways to make the process easier and more effective, so that young people receive the best possible care.
To participate in the study, clinic staff must be at least 21 years old and work at a clinic that is part of a special mental health initiative. Young people aged 13 to 17 who are receiving treatment at these clinics can also join. Participants can expect to be involved in training sessions, interviews, and discussions aimed at improving mental health care practices. It's important to note that those who are experiencing severe mental health issues, such as being suicidal or unable to communicate effectively, will not be eligible for this study. Overall, this trial aims to enhance the quality of care for youth by making sure that their progress is regularly assessed and that treatments are adjusted as needed.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aim 1: Co-create plans for optimizing Measurement Based Care (MBC) implementation for youth with comorbidities. Clinic staff/Therapists (N=180) across 6 CMHCs in Washington state.
- • Aged 21+
- • Working at a CMHC that is participating in the WA State CBT (Cognitive Behavioral Therapy) + Initiative.
- • Youth (N=48)
- • Aged 13-17 years
- • Receiving treatment at CMHC participating in the WA State CBT (Cognitive Behavioral Therapy) + Initiative.
- • Aim 2: Compare MBC fidelity post IMPACT Center methods deployment versus historical controls. Clinic staff/Therapists (N=30) across 6 CMHCs in Washington.
- • Must be aged 21+
- • Working at a CMHC that is participating in the WA State CBT (Cognitive Behavioral Therapy) + Initiative.
- Exclusion Criteria:
- • Aim 1: Clinic staff/Therapists: Unwilling to participate in study activities.
- * Youth:
- • Suicidal or psychotic
- • Not cognitively able to safely participate in MBC
- • Not able to read and write in English.
- * Aim 2: Clinic staff/Therapists:
- • Unwilling to participate in study activities.
Trial Officials
Ruben G Martinez, PhD
Study Director
Kaiser Permanente
About Kaiser Permanente
Kaiser Permanente is a leading integrated health care organization that combines a health plan with a network of hospitals and physicians to provide comprehensive medical services. With a strong commitment to advancing medical research and improving patient care, Kaiser Permanente sponsors clinical trials across various therapeutic areas. The organization emphasizes innovative approaches to health care, leveraging its extensive data and resources to support evidence-based treatments and enhance patient outcomes. Through its rigorous research initiatives, Kaiser Permanente aims to contribute to the advancement of medical knowledge and the development of new therapies that benefit diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials